Free Newsletter
BMS to sell off company jets
Bristol-Myers Squibb is getting out of the transportation business. It's planning to shut down its aviation operation in Ewing, NJ, selling its four private aircraft and laying off 32 pilots and other air transportation employees. The move is "designed to reduce corporate overhead" as part of Bristol's overall cost-cutting program, a spokeswoman said.
On the block will be two Gulfstream jets and two Sikorsky helicopters. BMS also will vacate its Trenton-Mercer airport hangar. Experts told the Star-Ledger that the jets could bring $40 million each and the helicopters $6 million a pop.
Now, the question is whether Bristol's neighbors at that airport will follow the company's lead. Pfizer, Johnson & Johnson and Merck all have aviation operations there.
- read the story in the Star-Ledger
- check out the Pharmalot post
ALSO: Who else is spending big bucks on private jets? Check out this list of the top 17 paychecks in Big Pharma to find out. Report
Related Articles:
BMS inks $710M development deal with PDL
ImClone builds case for higher takeover bid
Analysts: BMS lowballing ImClone
Comments
Post new comment
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges





Click here to get the FiercePharma email newsletter for FREE!
Be the first to comment